Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer
Clinical trial NCT01036087 · COMPLETED
Trial details
- NCT number
- NCT01036087
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2016-02-11
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.